HER3 beyond the canonical paradigm: a versatile signaling hub in oncogenesis and therapeutic resistance
Abstract Background Human epidermal growth factor receptor 3 (HER3/ErbB3) is classically recognized as a kinase-impaired member of the epidermal growth factor receptor (EGFR) family, which can initiate oncogenic signaling by heterodimerizing with family members. However, the emerging drug resistance...
Zapisane w:
| Główni autorzy: | , , , , |
|---|---|
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
BMC
2026-03-01
|
| Seria: | Journal of Translational Medicine |
| Hasła przedmiotowe: | |
| Dostęp online: | https://doi.org/10.1186/s12967-026-07934-4 |
| Etykiety: |
Nie ma etykietki, Dołącz pierwszą etykiete!
|